Integrated referrals NuReferrals combines par8o’s referral technology with NuvemRx’s TPA and pharmacy ownership services, creating a single, mission-aligned ecosystem. This presents a sales opportunity to position a unified solution that reduces fragmentation and outsourcing risk for health systems.

340B optimization The merger centers on recovering 340B savings through misclassified scripts and ineligible referrals, with AI-assisted automation claimed to handle a large portion of complex referral and eligibility processes. Target hospital networks with 340B programs seeking to maximize savings and compliance.

AI driven efficiency Acquired technology reportedly automates up to 85% of the complex referral and eligibility workflow. This highlights a compelling use case for health systems facing bottlenecks in specialty referrals, eligibility checks, and revenue leakage.

Leadership continuity Leadership integration, with the former par8o COO joining as COO of NuvemHealth, signals a stable transition and focus on integration value. This can be marketed to prospects as reduced risk and clear ownership for the combined solution.

Expansion-ready footprint The combined entity positions a complete referral management stack under one partner, appealing to providers overwhelmed by multiple vendors. This offers an upsell path to health centers seeking streamlined vendor relationships and end-to-end referrals, TPA, and pharmacy management.